TOMROK
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

TOMROK Trademark

Serial Number: 98687170

TOMROK is a trademark filed by Faraday Pharmaceuticals, Inc. on August 7, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Faraday Pharmaceuticals, Inc. (5 trademarks)

1616 Eastlake Avenue E, Suite 560
Seattle, WA 98102

Entity Type: 03

Trademark Details

Filing Date

August 7, 2024

Registration Date

Not Registered

Published for Opposition

March 18, 2025

Goods & Services

Pharmaceutical preparations for the prevention and treatment of cardiac and skeletal muscle function diseases and disorders

Providing a website featuring information concerning medical diagnosis and treatment of cardiac and skeletal muscle function diseases and disorders

Providing a website featuring information in the field of testing of pharmaceuticals; providing a website featuring information concerning medical research in the field of cardiac and skeletal muscle function diseases and disorders; research and development in the field of pharmaceuticals

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 11, 2025 EXRA
SOU EXTENSION 1 GRANTED
Oct 10, 2025 EX1G
SOU EXTENSION 1 FILED
Oct 10, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 10, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 13, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 21, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 21, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 21, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 21, 2025 CNEA
ASSIGNED TO EXAMINER
Feb 13, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2025 NWOS
NEW APPLICATION ENTERED
Aug 7, 2024 NWAP